Financial Performance - Fourth quarter net sales increased by 3.8% to $537.2 million, while full year net sales decreased by 1.3% to $2,223.5 million[5][20] - Organic net sales rose by 2.5% in the fourth quarter but decreased by 1.3% for the full year, with international markets showing organic growth of 3.5%[5][20] - Gross profit for fiscal 2025 was $924.9 million, with a gross margin of 41.6%, a decrease of 80 basis points from the prior year[21] - Operating income for fiscal 2025 was $96.6 million, or 4.3% of net sales, down from $199.3 million, or 8.8% of net sales, in the prior year[25] - The company reported a net loss of $30.6 million for the three months ended September 30, 2025, compared to net earnings of $8.8 million for the same period in 2024[43] - Net earnings for the twelve months ended September 30, 2025, were $25.4 million, down 74.2% from $98.6 million in 2024[49] - The company reported an EBIT of $219.1 million for the twelve months ended September 30, 2025, with a GAAP effective tax rate of (7.3)%[53] - The company reported an EBITDA of $(15.8) million for the three months ended September 30, 2025, compared to $43.3 million in the same period of 2024[59] Shareholder Returns - The company returned $120 million to shareholders through dividends and share repurchases in fiscal 2025, including a new share repurchase authorization for up to $100 million[5][28] Tax and Restructuring - GAAP diluted EPS for fiscal 2025 was $0.53, while adjusted EPS was $2.52, reflecting a $0.48 unfavorable impact from currency movements[5][26] - The effective tax rate for fiscal 2025 was a benefit of (7.3)%, compared to an expense of 18.5% in the prior year[14] - The adjusted effective tax rate is expected to be approximately 21% to 22%[32] - The company incurred restructuring and related costs of $3.5 million during the twelve months ended September 30, 2025, which affected overall profitability[53] - Restructuring and related costs for the three months ended September 30, 2025, were $18.3 million, compared to $22.8 million in the same period of 2024[59] Future Projections - Reported net sales are expected to increase by approximately 0.5% to 3.5%, with a positive impact of 150 basis points from foreign currency changes[32] - Organic net sales are projected to decrease by 1% to increase by 2%[32] - GAAP EPS is anticipated to be in the range of $1.10 to $1.50, including restructuring and related costs[32] - Adjusted EPS is expected to range from $2.15 to $2.55, with an estimated $0.28 per share favorable impact from foreign currency changes[32] - Adjusted EBITDA is projected to be between $290 million and $310 million[32] - Free cash flow is expected to be approximately $115 million to $145 million[32] - Fiscal 2026 Adjusted EBITDA is projected to be between $290 - $310 million, with GAAP Net Income expected to be approximately $51 - $70 million[63] Asset and Liability Management - Total assets increased to $3,756.3 million as of September 30, 2025, compared to $3,730.9 million in 2024, reflecting a growth of 0.7%[46] - Total liabilities rose to $2,203.2 million, an increase of 2.6% from $2,146.8 million in 2024[46] - The company’s total shareholders' equity decreased to $1,553.1 million as of September 30, 2025, from $1,584.1 million in 2024, a decline of 2.0%[46] - Net debt increased to $1,187.1 million as of September 30, 2025, compared to $1,090.4 million in 2024, representing an increase of approximately 8.9%[59] Segment Performance - Segment profit for Wet Shave decreased to $190.3 million for the twelve months ended September 30, 2025, down 6.5% from $203.9 million in 2024[51] - The Wet Shave segment experienced a decline in organic sales of 1.2% for the twelve months ended September 30, 2025, while the Fem Care segment saw a decline of 7.7%[57] - The total segment profit for the twelve months ended September 30, 2025, was $304.3 million, down 16.4% year-over-year, primarily due to adverse currency impacts[57] Impairment and Charges - The company recorded pre-tax restructuring costs of $53.1 million in fiscal 2025, aimed at improving cost efficiency[24] - The company reported impairment charges of $51.1 million for the twelve months ended September 30, 2025[51]

Core Insights - Edgewell Personal Care Company reported a 3.8% increase in fourth quarter net sales, reaching $537.2 million, with a 2.5% organic growth [5][12] - For fiscal year 2025, net sales decreased by 1.3% to $2,223.5 million, with organic sales also declining by 1.3% [12][16] - The company returned $120 million to shareholders through dividends and share repurchases during fiscal year 2025 [12][23] Financial Performance - Gross profit for the fourth quarter was $208.6 million, down from $212.8 million in the prior year, resulting in a gross margin of 38.8%, a decrease of 230 basis points [6][12] - Adjusted operating income for the fourth quarter was $40.3 million, or 7.5% of net sales, compared to $56.0 million, or 10.8% in the prior year [9][12] - The company recorded a net loss of $30.6 million for the fourth quarter, translating to a loss of $0.66 per diluted share, compared to a profit of $8.8 million or $0.17 per diluted share in the prior year [12][22] Segment Performance - Wet Shave segment net sales increased by 1.2% to $318.2 million, while organic net sales decreased by 0.8% due to volume declines in North America [13][38] - Sun and Skin Care segment net sales rose by 11.5% to $148.0 million, with organic growth of 11.1% driven by volume growth [14][38] - Feminine Care segment net sales increased slightly by 0.9% to $67.3 million, but segment profit decreased by 22.6% [15][38] Strategic Initiatives - The company announced the divestiture of its Feminine Care business to Essity for $340 million, marking a significant strategic shift [12][13] - Edgewell aims to return to organic sales growth in 2026, with a focus on execution, margin recovery, and sustainable shareholder value [4][12] - The company plans to incur pre-tax charges of approximately $49 million in fiscal 2026 for restructuring and efficiency improvements [25][24]

Core Insights - Edgewell Personal Care has agreed to sell its North American feminine care business to Essity for $340 million [1] Group 1: Transaction Details - The sale includes products such as Stayfree sanitary napkins [1] - The transaction is valued at $340 million [1] Group 2: Strategic Implications - The acquisition by Essity reflects its strategy to expand in the health and hygiene sector [1]

Core Insights - Essity has agreed to acquire Edgewell Personal Care's feminine care business for USD 340 million, enhancing its position in the North American hygiene market [1][3] - The acquisition includes well-known brands such as Carefree, Stayfree, and o.b., as well as global rights for Playtex and a production facility in Dover, Delaware [1][3] - The deal is expected to close in the first quarter of 2026, pending regulatory approvals [1] Financial Summary - The purchase price of USD 340 million represents an EBITDA multiple of approximately 12.1x based on pro-forma IFRS as of June 30, 2025, and 8.3x when including estimated run-rate synergies [1] - For the 12 months ending June 30, 2025, the acquired business reported net sales of USD 261 million and a segment operating profit of USD 17 million [1] Strategic Implications - This acquisition aligns with Essity's strategy to focus on high-margin categories and strengthen its market position in the US, the largest hygiene market globally [1] - Essity aims to leverage its established success in the feminine care sector to grow the acquired brands [1]

Core Viewpoint - Edgewell Personal Care Company has entered into a definitive agreement to sell its feminine care business to Essity for $340 million, aiming to streamline its portfolio and focus on core competitive areas [1][2][3]. Transaction Details - The transaction is expected to close in the first quarter of calendar 2026, pending regulatory approvals [2]. - Edgewell's feminine care brands include Playtex®, Stayfree®, Carefree®, and o.b.® [2]. - Proceeds from the sale will primarily be used to strengthen Edgewell's balance sheet and invest in long-term growth of its core businesses [2]. Strategic Implications - The sale is seen as a pivotal step in Edgewell's transformation, allowing the company to sharpen its focus on core categories and enhance its financial position for sustainable growth [3]. - The acquisition will enable Essity to strengthen its personal care business in North America, aligning with its strategy to focus on high-yield categories [3]. Transition Support - Edgewell will collaborate with Essity to ensure a smooth transition for employees, customers, and consumers, providing certain services to support the transition post-transaction [4]. Financial Impact - Beginning in the first quarter of fiscal 2026, Edgewell will classify the feminine care business as discontinued operations [5]. - The sale is expected to impact adjusted EPS by approximately $0.40 to $0.50 and adjusted EBITDA by $35 to $45 million, net of income from transition support services [5].

Core Insights - Edgewell Personal Care (EPC) is set to release its fourth-quarter 2025 earnings on November 13, with an anticipated earnings per share (EPS) of $0.82 and projected revenue of $532.82 million, which could influence stock movement [1] Financial Performance - The expected EPS of $0.82 indicates a 13.9% increase from the same period last year, reflecting the company's growth trajectory [2] - The projected revenue of $532.82 million represents a 3.6% rise from the previous year's quarter, despite a prior revenue decline of 3.2% reported on August 5 [3] - The previous earnings report showed earnings of $0.92 per share, missing analysts' expectations of $1.01, with revenue falling short of the forecasted $658.51 million [3] Market Valuation - EPC has a price-to-earnings (P/E) ratio of approximately 13.70, indicating moderate market valuation of its earnings [4] - The price-to-sales ratio of 0.39 and enterprise value to sales ratio of 0.94 suggest a relatively low market valuation compared to its revenue [4] - The company's debt-to-equity ratio of 0.90 reflects a balanced approach to leveraging debt versus equity [4] Financial Stability - EPC's current ratio of 1.77 demonstrates its ability to cover short-term liabilities with short-term assets, indicating a stable financial footing [5]

Core Insights - Crude Value Insights provides an investment service and community focused on the oil and natural gas sector, emphasizing cash flow and the companies that generate it [1] - The service includes access to a 50+ stock model account, in-depth cash flow analyses of exploration and production (E&P) firms, and live chat discussions about the sector [1] Offerings - Subscribers can take advantage of a two-week free trial to explore the services related to oil and gas investments [2]

Core Viewpoint - Edgewell Personal Care (EPC) is anticipated to report a year-over-year increase in earnings driven by higher revenues for the quarter ended September 2025, with the consensus outlook indicating a potential impact on its near-term stock price based on actual results compared to estimates [1][2]. Earnings Expectations - The upcoming earnings report is scheduled for November 13, and if the reported figures exceed expectations, the stock may experience upward movement; conversely, a miss could lead to a decline [2]. - The Zacks Consensus Estimate predicts quarterly earnings of $0.82 per share, reflecting a year-over-year increase of 13.9%, while revenues are expected to reach $536.03 million, marking a 3.6% increase from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 4.55%, indicating a reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Edgewell Personal is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -2.04%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model compares the Most Accurate Estimate to the Zacks Consensus Estimate, with a positive Earnings ESP indicating a higher likelihood of an earnings beat, particularly when combined with a strong Zacks Rank [8][10]. - Edgewell Personal currently holds a Zacks Rank of 4, which, combined with the negative Earnings ESP, complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Edgewell Personal was expected to post earnings of $1.01 per share but only achieved $0.92, resulting in a surprise of -8.91% [13]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [14]. Conclusion - While Edgewell Personal does not appear to be a strong candidate for an earnings beat, investors should consider other factors when making decisions regarding the stock ahead of the earnings release [17].

Core Viewpoint - Edgewell Personal Care Company is set to report its financial results for the fourth quarter and fiscal year 2025 on November 13, 2025, before market opening, with a conference call scheduled for the same day to discuss the results [1]. Company Overview - Edgewell Personal Care is a leading pure-play consumer products company with a diversified portfolio of established brands, including Schick®, Wilkinson Sword®, Billie®, Edge®, Skintimate®, Playtex®, Stayfree®, Carefree®, o.b.®, Banana Boat®, Hawaiian Tropic®, Bulldog®, Jack Black®, Cremo®, and Wet Ones® [2]. - The company operates in over 50 markets globally, including the U.S., Canada, Mexico, Germany, Japan, the U.K., and Australia, employing approximately 6,700 people worldwide [2]. Recent Developments - Edgewell Personal Care announced a new leadership structure aimed at streamlining operations and enhancing efficiency, with the departure of Chief Operating Officer Dan Sullivan effective October [3]. - The company has been recognized as the 1 employer in Connecticut on Forbes America's Best-In-State Employers 2025 list, highlighting its strong employer brand [4].

Core Insights - The Vanguard S&P Small-Cap 600 Value ETF (VIOV) has an implied analyst target price of $105.50 per unit, indicating a potential upside of 11.80% from its recent trading price of $94.37 [1][2][3] Summary by Category ETF Overview - VIOV is currently trading at $94.37, with analysts projecting a target price of $105.50, reflecting an 11.80% upside [2][3] Underlying Holdings - Notable underlying holdings with significant upside potential include: - Minerals Technologies, Inc. (MTX): Recent price of $63.03, target price of $82.00, representing a 30.10% upside [2][3] - Sun Country Airlines Holdings Inc (SNCY): Recent price of $13.11, target price of $16.55, indicating a 26.28% upside [2][3] - Edgewell Personal Care Co (EPC): Recent price of $21.67, target price of $26.00, showing a 19.98% upside [2][3] Analyst Target Price Analysis - The analysis raises questions about whether analysts' targets are justified or overly optimistic, suggesting the need for further investor research into recent company and industry developments [3]